Aldeyra Therapeutics, Inc. announced the appointment of Richard H. Douglas, Ph.D. to the Board of Directors of the company. Dr. Douglas is the former Senior Vice President, Corporate Development, Genzyme Corporation. Prior to his work at Genzyme Corporation, Dr. Douglas served in science and corporate development capacities at Integrated Genetics.